| EBOV Presumptive Positive Patient | BOMV Presumptive Positive Patient | Negative Human | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Peptide | NP | VP35 | VP40 | GP | VP30 | VP24 | L | Tot | NP | VP35 | VP40 | GP | VP30 | VP24 | L | Tot | NP | VP35 | VP40 | GP | VP30 | VP24 | L | Tot |
EBOV | 2 | Â | 1 | 3 | Â | Â | 3 | 9 | 9 | Â | 4 | 10 | 4 | Â | 16 | 43 | Â | Â | Â | Â | Â | Â | Â | Â |
BOMV | 4 | Â | Â | 2 | 1 | Â | 4 | 11 | 10 | 6 | 3 | 10 | 3 | 2 | 18 | 52 | Â | 1 | Â | 1 | Â | Â | 1 | 3 |
SUDV | Â | Â | Â | 1 | Â | 1 | 2 | 4 | 8 | Â | 1 | 12 | 5 | Â | 16 | 42 | Â | Â | Â | 1 | Â | Â | 1 | 2 |
BDBV | 2 | Â | Â | 3 | 1 | Â | 4 | 10 | 7 | Â | 1 | 10 | 2 | Â | 15 | 35 | Â | Â | Â | Â | Â | Â | Â | Â |
TAFV | 3 | Â | Â | Â | 1 | Â | 2 | 6 | 9 | Â | 3 | 10 | 2 | Â | 18 | 42 | Â | Â | Â | Â | Â | Â | Â | Â |
REST | 3 | Â | Â | 2 | Â | Â | 4 | 9 | 9 | Â | Â | 11 | 3 | Â | 18 | 41 | 2 | Â | Â | 3 | Â | Â | Â | 5 |
MARV | 2 | Â | Â | Â | Â | Â | 1 | 3 | 9 | Â | 4 | 13 | 3 | Â | 22 | 51 | Â | Â | Â | 2 | 1 | Â | Â | 3 |